References
Xie W, Robertson DL, Simmons D. Mitogen-inducible prostaglanding G/H synthase: a new target for non-steroidal antiinflammatory drugs. Drug Dev Res 1992;25:249–65.
Aabakken L. Non-steroidal, antiinflammatory drugs—the extending scope of gastrointestinal side effects. Aliment Pharmacol Ther 1992;6:143–62.
Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New Eng J Med 1984;310:563–72.
Futaki N, Takahashi S, Yokoyama M, Arai S, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55–9.
Gierse J, Hauser S, Creely B, Rangwala S, Koboldt C, Isakson P, et al. Expression and selective inhibition of human cyclooxygenase 1 and 2. Biochem J. In press.
Summers MD, Smith GE. A Manual of Methods for baculovirus vectors and insect cell culture procedures. Texas Agric Exp Station Bull 1987;1555.
Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huff, R., Collins, P., Kramer, S. et al. A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2). Inflamm Res 44 (Suppl 2), S145–S146 (1995). https://doi.org/10.1007/BF01778304
Issue Date:
DOI: https://doi.org/10.1007/BF01778304